サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439450

脳脊髄液（CSF）管理 - 世界市場の考察、競合情勢、市場予測（2030年）

Cerebrospinal Fluid Management - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
脳脊髄液（CSF）管理 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脳脊髄液（CSF）管理の市場規模は、2024年～2030年の予測期間にCAGRで4.78%の成長が見込まれます。事故や外傷の件数の増加、脳腫瘍の有病率の増加、小児水頭症の患者の増加、先進技術を利用した製品に対する需要の高まり、老年人口の増加などによって脳脊髄液（CSF）管理に対する需要が伸びており、世界の脳脊髄液（CSF）管理市場における製品需要を促進すると予測されます。

脳脊髄液（CSF）管理の市場力学

脳脊髄液（CSF）管理市場は、脳腫瘍の有病率の上昇により市場収益の増加を示しています。脳腫瘍は脳内のCSFの蓄積と関連しており、最終的に脳内の頭蓋内圧の上昇をもたらします。International Agency for Research on Cancerが2020年に発表したGLOBOCANの調査によると、脳腫瘍は2020年に全世界で30万8,102件を占める。過剰な体液は脳を圧迫し、脳にダメージを与えます。そのため、脳内に液体が溜まるのを避けるために、CSFシャントやドレナージシステムなどのCSF管理デバイスが採用されています。そのため、脳腫瘍の世界の増加によりCSF管理デバイスの需要が高まり、世界の髄液管理市場の成長につながると予測されます。

交通事故による負傷の増加も、CSF管理デバイス市場の主な成長要因の1つと考えられます。交通事故による負傷に関する世界保健機関（WHO）のファクトシート（2023）によると、交通事故に伴う負傷は、世界中の5～29歳の子供と若年成人の死因の第1位です。同ファクトシートはさらに、約2,000万～5,000万人近くが交通事故による非致死的負傷に苦しみ、その結果、障害が残っていると述べています。このような性質の負傷は、重度の頭部外傷につながる可能性があります。その結果、脳内に血栓が形成され、脳内のCSFの流れが制限されることがあります。その結果、脳内にCSFが蓄積し、CSF管理デバイスの助けを借りて治療することになります。そのため、交通事故や負傷の増加は、脳脊髄液（CSF）管理デバイスに対する需要の増加に寄与し、ひいては予測期間に世界の脳脊髄液（CSF）管理市場を前進させると見込まれます。

しかし、厳格な製品承認プロセスや、感染、シャント機能不全、不適切なドレナージなど、デバイスに関連する一般的なリスクが、脳脊髄液（CSF）管理市場の成長に対する一定の抑制要因となる可能性があります。

上記の要因とともに、世界の脳脊髄液（CSF）管理市場は、COVID-19の蔓延を抑制するために必要な措置として全国的なロックダウンなどが課されたため、一時的に後退した時期がありました。この間の主な措置の1つは、多数の選択的手術と外来受診の停止でした。このため、さまざまな診療科にわたる多数の手術が必要不可欠でないという理由で中断されたり、ロックダウン初期に患者数が減少したために集中治療室のいくつかが閉鎖されたりして、市場におけるCSF管理デバイスの需要が減少し、それによって市場の成長が短期間制限されました。しかし、脳脊髄液（CSF）管理デバイス市場は、世界中で多数のCOVID-19ワクチンが承認され投与されたことにより、医療サービスを含むさまざまな領域で活動が再開され、回復期を迎えています。

脳脊髄液（CSF）管理市場のセグメント分析

CSF管理市場の製品セグメントでは、CSFシャントとバルブが予測期間に市場で大きな収益シェアを占める見込みです。これは、脳室内出血や二分脊椎による水頭症/液貯留向けに小児患者にもっとも一般的に設置され、これらの状態に関連する臨床転帰を大きく改善していることから、水頭症治療への適用可能性によるものと考えられます。さらに、その他のCSF管理デバイスと比較して、生涯使用することを目的としているため、より永続的な治療アプローチを提供します。

さらに、CSFの過剰排出を回避する電子（外部）プログラム可能なコンポーネントを備えた新型スタントの開発など、製品開発における技術の進歩も、CSF管理市場におけるこの製品タイプの需要にプラスの影響を与える一因となる可能性があります。

当レポートでは、世界の脳脊髄液（CSF）管理市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 脳脊髄液（CSF）管理市場レポートのイントロダクション

第2章 脳脊髄液（CSF）管理市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 脳脊髄液（CSF）管理市場の主な要因の分析

  • 脳脊髄液（CSF）管理市場の促進要因
    • 水頭症の有病率の上昇
    • 外傷と事故の件数の増加
    • 脳腫瘍の有病率の上昇
    • 革新的な製品開発への注目の高まり
  • 脳脊髄液（CSF）管理市場の抑制要因と課題
    • デバイスに関連するリスク
    • 厳格な製品承認プロセス
  • 脳脊髄液（CSF）管理市場の機会
    • 抗菌性を持つデバイスの開発
    • 製品の安全面の向上

第5章 脳脊髄液（CSF）管理市場のポーターのファイブフォース分析

第6章 脳脊髄液（CSF）管理市場に対するCOVID-19の影響の分析

第7章 脳脊髄液（CSF）管理市場のレイアウト

  • 製品タイプ別
    • CSFシャント、バルブ
    • 体外ドレナージシステム
    • アンチサイフォンデバイス
    • その他
  • 年齢層別
    • 成人
    • 小児
  • エンドユーザー別
    • 病院
    • 専門クリニック
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 脳脊髄液（CSF）管理市場：世界の企業シェア分析 - 主要3～5社

第9章 脳脊髄液（CSF）管理市場の企業と製品のプロファイル

  • Medtronic
  • B. Braun Melsungen AG
  • Neuromedex GmbH
  • Natus Medical Incorporated
  • Sophysa
  • Integra LifeSciences Corporation
  • Spiegelberg GmbH & Co. KG
  • Desu Medical
  • Polyganics
  • CHRISTOPH MIETHKE GMBH & CO. KG
  • HpBio Proteses Inc
  • Wellong Instruments Co., Ltd.
  • Moller Medical GmbH
  • RAUMEDIC AG
  • Anuncia Inc
  • Vivonics Inc
  • CereVasc Inc

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項と連絡先

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market
  • Table 3 Cerebrospinal Fluid Management Market in Global (2021-2030)
  • Table 4 Cerebrospinal Fluid Management Market in Global by Product Type (2021-2030)
  • Table 5 Cerebrospinal Fluid Management Market in Global by Age Group (2021-2030)
  • Table 6 Cerebrospinal Fluid Management Market in Global by End User (2021-2030)
  • Table 7 Cerebrospinal Fluid Management Market in Global by Geography (2021-2030)
  • Table 8 Cerebrospinal Fluid Management Market in North America (2021-2030)
  • Table 9 Cerebrospinal Fluid Management Market in North America by Product Type (2021-2030)
  • Table 10 Cerebrospinal Fluid Management Market in North America by Age Group (2021-2030)
  • Table 11 Cerebrospinal Fluid Management Market in North America by End User (2021-2030)
  • Table 12 Cerebrospinal Fluid Management Market in North America by Country (2021-2030)
  • Table 13 Cerebrospinal Fluid Management Market in the US (2021-2030)
  • Table 14 Cerebrospinal Fluid Management Market in Canada (2021-2030)
  • Table 15 Cerebrospinal Fluid Management Market in Mexico (2021-2030)
  • Table 16 Cerebrospinal Fluid Management Market in Europe (2021-2030)
  • Table 17 Cerebrospinal Fluid Management Market in Europe by Product Type (2021-2030)
  • Table 18 Cerebrospinal Fluid Management Market in Europe by Age Group (2021-2030)
  • Table 19 Cerebrospinal Fluid Management Market in Europe by End User (2021-2030)
  • Table 20 Cerebrospinal Fluid Management Market in Europe by Country (2021-2030)
  • Table 21 Cerebrospinal Fluid Management Market in France (2021-2030)
  • Table 22 Cerebrospinal Fluid Management Market in Germany (2021-2030)
  • Table 23 Cerebrospinal Fluid Management Market in the United Kingdom (2021-2030)
  • Table 24 Cerebrospinal Fluid Management Market in Italy (2021-2030)
  • Table 25 Cerebrospinal Fluid Management Market in Spain (2021-2030)
  • Table 26 Cerebrospinal Fluid Management Market in Russia (2021-2030)
  • Table 27 Cerebrospinal Fluid Management Market in Rest of Europe (2021-2030)
  • Table 28 Cerebrospinal Fluid Management Market in APAC (2021-2030)
  • Table 29 Cerebrospinal Fluid Management Market in APAC by Product Type (2021-2030)
  • Table 30 Cerebrospinal Fluid Management Market in APAC by Age Group (2021-2030)
  • Table 31 Cerebrospinal Fluid Management Market in APAC by End User (2021-2030)
  • Table 32 Cerebrospinal Fluid Management Market in APAC by Country (2021-2030)
  • Table 33 Cerebrospinal Fluid Management Market in China (2021-2030)
  • Table 34 Cerebrospinal Fluid Management Market in Japan (2021-2030)
  • Table 35 Cerebrospinal Fluid Management Market in India (2021-2030)
  • Table 36 Cerebrospinal Fluid Management Market in Australia (2021-2030)
  • Table 37 Cerebrospinal Fluid Management Market in South Korea (2021-2030)
  • Table 38 Cerebrospinal Fluid Management Market in Rest of APAC (2021-2030)
  • Table 39 Cerebrospinal Fluid Management Market in Rest of World (2021-2030)
  • Table 40 Cerebrospinal Fluid Management Market in RoW by Product Type (2021-2030)
  • Table 41 Cerebrospinal Fluid Management Market in RoW by Age Group (2021-2030)
  • Table 42 Cerebrospinal Fluid Management Market in RoW by End User (2021-2030)
  • Table 43 Cerebrospinal Fluid Management Market in RoW by Region (2021-2030)
  • Table 44 Cerebrospinal Fluid Management Market in Middle East (2021-2030)
  • Table 45 Cerebrospinal Fluid Management Market in Africa (2021-2030)
  • Table 46 Cerebrospinal Fluid Management Market in South America (2021-2030)

List of Figures

Figures 1 Competitive Analysis

Figures 2 COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market

Figures 3 Cerebrospinal Fluid Management Market in Global (2021-2030)

Figures 4 Cerebrospinal Fluid Management Market in Global by Product Type (2021-2030)

Figures 5 Cerebrospinal Fluid Management Market in Global by Age Group (2021-2030)

Figures 6 Cerebrospinal Fluid Management Market in Global by End User (2021-2030)

Figures 7 Cerebrospinal Fluid Management Market in Global by Geography (2021-2030)

Figures 8 Cerebrospinal Fluid Management Market in North America (2021-2030)

Figures 9 Cerebrospinal Fluid Management Market in North America by Product Type (2021-2030)

Figures 10 Cerebrospinal Fluid Management Market in North America by Age Group (2021-2030)

Figures 11 Cerebrospinal Fluid Management Market in North America by End User (2021-2030)

Figures 12 Cerebrospinal Fluid Management Market in North America by Country (2021-2030)

Figures 13 Cerebrospinal Fluid Management Market in the US (2021-2030)

Figures 14 Cerebrospinal Fluid Management Market in Canada (2021-2030)

Figures 15 Cerebrospinal Fluid Management Market in Mexico (2021-2030)

Figures 16 Cerebrospinal Fluid Management Market in Europe (2021-2030)

Figures 17 Cerebrospinal Fluid Management Market in Europe by Product Type (2021-2030)

Figures 18 Cerebrospinal Fluid Management Market in Europe by Age Group (2021-2030)

Figures 19 Cerebrospinal Fluid Management Market in Europe by End User (2021-2030)

Figures 20 Cerebrospinal Fluid Management Market in Europe by Country (2021-2030)

Figures 21 Cerebrospinal Fluid Management Market in France (2021-2030)

Figures 22 Cerebrospinal Fluid Management Market in Germany (2021-2030)

Figures 23 Cerebrospinal Fluid Management Market in the United Kingdom (2021-2030)

Figures 24 Cerebrospinal Fluid Management Market in Italy (2021-2030)

Figures 25 Cerebrospinal Fluid Management Market in Spain (2021-2030)

Figures 26 Cerebrospinal Fluid Management Market in Russia (2021-2030)

Figures 27 Cerebrospinal Fluid Management Market in Rest of Europe (2021-2030)

Figures 28 Cerebrospinal Fluid Management Market in APAC (2021-2030)

Figures 29 Cerebrospinal Fluid Management Market in APAC by Product Type (2021-2030)

Figures 30 Cerebrospinal Fluid Management Market in APAC by Age Group (2021-2030)

Figures 31 Cerebrospinal Fluid Management Market in APAC by End User (2021-2030)

Figures 32 Cerebrospinal Fluid Management Market in APAC by Country (2021-2030)

Figures 33 Cerebrospinal Fluid Management Market in China (2021-2030)

Figures 34 Cerebrospinal Fluid Management Market in Japan (2021-2030)

Figures 35 Cerebrospinal Fluid Management Market in India (2021-2030)

Figures 36 Cerebrospinal Fluid Management Market in Australia (2021-2030)

Figures 37 Cerebrospinal Fluid Management Market in South Korea (2021-2030)

Figures 38 Cerebrospinal Fluid Management Market in Rest of APAC (2021-2030)

Figures 39 Cerebrospinal Fluid Management Market in Rest of World (2021-2030)

Figures 40 Cerebrospinal Fluid Management Market in RoW by Product Type (2021-2030)

Figures 41 Cerebrospinal Fluid Management Market in RoW by Age Group (2021-2030)

Figures 42 Cerebrospinal Fluid Management Market in RoW by End User (2021-2030)

Figures 43 Cerebrospinal Fluid Management Market in RoW by Region (2021-2030)

Figures 44 Cerebrospinal Fluid Management Market in Middle East (2021-2030)

Figures 45 Cerebrospinal Fluid Management Market in Africa (2021-2030)

Figures 46 Cerebrospinal Fluid Management Market in South America (2021-2030)

Figures 47 Market Drivers

Figures 48 Market Barriers

Figures 49 Marker Opportunities

Figures 50 PORTER'S Five Force Analysis

目次
Product Code: DIMDCL0257

Cerebrospinal Fluid Management Market By Product Type (Csf Shunts & Valves, External Drainage Systems [Drainage And Monitoring Systems, Drainage-Specific Systems, And Csf Drainage Catheters {Ventricular, Lumbar, And Others}], Anti-Siphon Devices, And Others), By Age Group (Adult And Pediatric), By End User (Hospitals And Specialty Clinics), by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of hydrocephalus due to brain tumors and road accidents.

Global Cerebrospinal Fluid Management Market will grow at a CAGR of 4.78% during the forecast period from 2024 to 2030. The demand for CSF management is witnessing growth due to the rising number of accident and trauma cases, growing prevalence of brain tumors, increasing cases of childhood hydrocephalus, rising demand for technologically advanced products, and increasing geriatric population are expected to drive the product demand in the global CSF management market.

Cerebrospinal Fluid Management Market Dynamics:

The cerebrospinal fluid (CSF) management market is witnessing an increase in market revenue owing to the rising prevalence of brain tumors. Brain tumors are associated with the accumulation of CSF in the brain which ultimately result in the increase of the intracranial pressure inside the brain. As per the GLOBOCAN study published by the International Agency for Research on Cancer published in 2020, brain cancers accounted for 308,102 cases across the globe in 2020. The excess fluid puts pressure on the brain, which can damage it. Therefore, in order to avoid the fluid buildup inside the brain, CSF management devices such as CSF shunts and drainage systems are employed. Therefore, the rising global prevalence of brain tumors is expected to result in the growing demand for CSF management devices, thereby aiding in the global CSF management market growth.

Increasing cases of road traffic injuries can be considered as another key factor responsible for the growth of the CSF management devices market. According to the World Health Organization factsheet (2023) on road traffic injuries, injuries associated with road accidents are the leading cause of fatality in children and young adults belonging to the age group 5-29 years across the globe. The same factsheet further stated that near about 20-50 million people suffer from non-fatal injuries in road accidents resulting in a disability as a result of their injury. Injuries of this nature may result in severe head trauma. This may result in formation of blood clots inside the brain which may restrict the flow of CSF inside the brain. This in turn leads to the accumulation of CSF inside the brain, which in turn would be treated with the help of CSF management devices. Therefore, the increase in the cases of road traffic injuries and accidents is expected to contribute in the growing demand for cerebrospinal fluid management devices, eventually taking the global cerebrospinal fluid management market forward during the forecast period.

However, stringent product approval process, common risks associated with the devices such as infection, shunt malfunction, and improper drainage, among others may prove to be certain restraints to the CSF management market growth.

Along with the above-mentioned factors, the global cerebrospinal fluid management market witnessed a period of temporary setback as necessary measures to contain the COVID-19 spread were imposed such as country-wide lockdowns. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for CSF management devices in the market as a large number of surgeries across different medical specialties were suspended on account of either being non-essential or several of intensive care units were closed because of the reduction in number of patient during the initial lockdown period, thereby limiting the market growth for a short time. However, the market for CSF management devices is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the cerebrospinal fluid management market during the forecast period.

Cerebrospinal Fluid Management Market Segment Analysis:

Cerebrospinal Fluid Management Market by Product Type (CSF Shunts & Valves, External Drainage Systems [Drainage and Monitoring Systems, Drainage-specific Systems, and CSF Drainage Catheters {Ventricular, Lumbar, and Others}], Anti-Siphon Devices, and Others), by Age Group (Adult and Pediatric), by End User (Hospitals and Specialty Clinics), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the CSF management market, the CSF shunts and valves are expected to account for a significant revenue share in the market during the forecast period. This can be attributed to their applicability in the treatment of hydrocephalus as they are most commonly placed in pediatric patients for hydrocephalus/fluid space collections due to intraventricular hemorrhage or spina bifida and have significantly improved clinical outcomes associated with these conditions. Furthermore, they offer a more permanent treatment approach compared to other CSF management devices as they are intended to remain in place for life.

Additionally, the technological advancement in product development such as the development of newer stunts with an electronically (externally) programmable component that would be help avoid over-drainage of CSF may be another key factor positively influencing the demand for this product type in the CSF management market.

North America is expected to dominate the Overall Cerebrospinal Fluid Management Market:

Among all the regions, North America is estimated to account for the significant market share in the CSF management market. North America is predicted to account for the dominant market share because of the high prevalence of hydrocephalus from various reasons such as congenital hydrocephalus, brain aneurysms, traumatic brain injury among other factors, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

The North America CSF management market is witnessing an upward trend due to the rising prevalence of congenital hydrocephalus in the country among other factors. As per the data provided by the Centers for Disease Control and Prevention, each year, about 1,427 babies are born with spina bifida, or 1 in every 2,758 births in the country. Many babies born with spina bifida also develop hydrocephalus which may boost the demand for CSF management devices such as hydrocephalus shunts, eventually driving the United States CSF management market growth during the forecast period.

Additionally, according to the data (2023) provided by the Brain Aneurysm Foundation, a US-based organization, an estimated 6.5 million people in the United States have an un-ruptured brain aneurysm. The annual rate of rupture in the country is approximately 8 - 10 per 100,000 people. About 30,000 people in the United States suffer a brain aneurysm rupture each year. A brain aneurysm ruptures every 18 minutes. It has been established that blood from a torn aneurysm can result in the blockage of CSF circulation leading to fluid buildup and increased pressure on the brain ultimately causing hydrocephalus. Therefore, the increase in number of patients suffering from brain aneurysms in the country is expected to drive the demand for CSF management devices, thereby contributing in the overall growth of the CSF management market in the North American region.

The above-mentioned facts point towards the presence of diverse patient pool in the country as well as the North American region that may benefit from the utilization of CSF management. Furthermore, the well-established patient care system along with awareness among patients and caregivers regarding different types of neurosurgeries and products used is further expected to aid in the North American CSF management market growth.

Moreover, the prompt and well-established healthcare services and infrastructure further contributes to the growth of the regional CSF management market. The presence of key players in the region and supportive reimbursement programs further provide immense growth opportunities for CSF management market. Moreover, the constant focus of market players in targeting the region in product launch is further expected to aid in the growth of the North American CSF management market. For instance, in December 2019, Raumedic AG launched a new device for home use, Raumed Home ICP for intracranial pressure (ICP) monitoring in hydrocephalus patients.

Cerebrospinal Fluid Management Market Key Players:

Some of the key market players operating in the CSF management market includes Medtronic, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated., Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical, Polyganics, CHRISTOPH MIETHKE GMBH & CO. KG, HpBio Proteses Inc, Wellong Instruments Co., Ltd., Moller Medical GmbH, CereVasc, Inc., Anuncia Inc, RAUMEDIC AG, Vivonics Inc and others.

Recent Developmental Activities in Cerebrospinal Fluid Management Market:

In March 2022, Anuncia Inc. received the ""Breakthrough Device Designation"" for ReFlow(TM) System Mini by the US FDA. The device is to be used in the treatment of CSF disorders requiring shunting such as hydrocephalus.

In May, 2020, Aesculap, Inc. announced the launch of M.blue(TM) Hydrocephalus Valve in the United States. The device is equipped with a unique gravitational technology integrated with a fixed differential pressure unit in one valve, thereby providing a simple, position-dependent solution.

In July 2019, Integra LifeSciences Holdings Corporation acquired Arkis Biosciences Inc. thereby also acquiring a portfolio of neurosurgical devices, including the CerebroFlo external ventricular drainage (EVD) catheter with Endexo technology.

Key Takeaways from the Cerebrospinal Fluid Management Market Report Study

Market size analysis for current CSF management market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the CSF management market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global CSF management market.

Various opportunities available for the other competitor in the CSF management market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current CSF management market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for CSF management market growth in the coming future?

Target Audience who can be benefited from this Cerebrospinal Fluid Management Market Report Study

Cerebrospinal Fluid Management products providers

Research organizations and consulting companies

Cerebrospinal Fluid Management-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in CSF management

Various End-users who want to know more about the CSF management market and latest technological developments in the CSF management market.

Frequently Asked Questions for Cerebrospinal Fluid Management Market:

1. What is a CSF Management Device?

CSF management devices are used in the treatment of CSF accumulation and leakage in events of hydrocephalus and injuries due to various reasons such as birth defects, trauma, and other causes. These include devices such as CSF shunts, dural sealants, and intracranial pressure monitoring devices among others.

2. What is the market for Global Cerebrospinal Fluid Management?

Global Cerebrospinal Fluid Management Market will grow at a CAGR of 4.78% during the forecast period from 2024 to 2030.

3. What are the drivers for Global Cerebrospinal Fluid Management Market?

The demand for CSF management is witnessing growth due to the rising number of accident and trauma cases, growing prevalence of brain tumors, increasing cases of childhood hydrocephalus, rising demand for technologically advanced products, and increasing geriatric population are expected to drive the product demand in the global CSF management market.

4. Who are the key players operating in Global Cerebrospinal Fluid Management Market?

Some of the key market players operating in the CSF management market includes Medtronic, B. Braun Melsungen AG, Neuromedex GmbH, Natus Medical Incorporated., Sophysa, Integra LifeSciences Corporation, Spiegelberg GmbH & Co. KG, Desu Medical, Polyganics, CHRISTOPH MIETHKE GMBH & CO. KG, HpBio Proteses Inc, Wellong Instruments Co., Ltd., Moller Medical GmbH, CereVasc, Inc., Anuncia Inc, RAUMEDIC AG, Vivonics Inc and others.

5. Which region has the highest share in Cerebrospinal Fluid Management market?

North America is predicted to account for the dominant market share because of the high prevalence of hydrocephalus from various reasons such as congenital hydrocephalus, brain aneurysms, traumatic brain injury among other factors, rising population of the elderly as well as high awareness among people regarding disease management and the new product launches in the region.

Table of Contents

1.Cerebrospinal Fluid Management Market Report Introduction

2.Cerebrospinal Fluid Management Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Cerebrospinal Fluid Management Market Key Factors Analysis

  • 4.1 Cerebrospinal Fluid Management Market Drivers
    • 4.1.1 Rising Prevalence of Hydrocephalus
    • 4.1.2 Rising Number of Trauma and Accident Cases
    • 4.1.3 Rising Prevalence of Brain Tumors
    • 4.1.4 Increasing Focus on Innovative Product Development
  • 4.2 Cerebrospinal Fluid Management Market Restraints and Challenges
    • 4.2.1 Risks Associated with Devices
    • 4.2.2 Stringent Product Approval Process
  • 4.3 Cerebrospinal Fluid Management Market Opportunities
    • 4.3.1 Development of Devices with Antimicrobial Properties
    • 4.3.2 Product Improvement in Terms of Safety

5. Cerebrospinal Fluid Management Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Cerebrospinal Fluid Management Market

7. Cerebrospinal Fluid Management Market Layout

  • 7.1 By Product Type
    • 7.1.1 CSF Shunts and Valves
    • 7.1.2 External Drainage Systems
      • 7.1.2.1 Drainage and Monitoring Systems
      • 7.1.2.2 Drainage-Specific Systems
      • 7.1.2.3 CSF Drainage Catheters
      • 7.1.2.3.1 Ventricular
      • 7.1.2.3.2 Lumbar
      • 7.1.2.3.3 Others
    • 7.1.4 Anti-Siphon Devices
    • 7.1.5 Others
  • 7.2 By Age Group
    • 7.2.1 Adult
    • 7.2.2 Pediatric
  • 7.3 By End User
    • 7.3.1 Hospitals
    • 7.3.2 Specialty Clinics
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Cerebrospinal Fluid Management Market, by Product Type
      • 7.4.1.2 North America Cerebrospinal Fluid Management Market, by Age Group
      • 7.4.1.2 North America Cerebrospinal Fluid Management Market, by End User
      • 7.4.1.4 North America Cerebrospinal Fluid Management Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Cerebrospinal Fluid Management Market, by Product Type
      • 7.4.2.2 Europe Cerebrospinal Fluid Management Market, by Age Group
      • 7.4.2.2 Europe Cerebrospinal Fluid Management Market, by End User
      • 7.4.2.4 Europe Cerebrospinal Fluid Management Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.2.6 Russia
      • 7.4.2.2.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Cerebrospinal Fluid Management Market, by Product Type
      • 7.4.3.2 Asia-Pacific Cerebrospinal Fluid Management Market, by Age Group
      • 7.4.3.2 Asia-Pacific Cerebrospinal Fluid Management Market, by End User
      • 7.4.3.4 Asia-Pacific Cerebrospinal Fluid Management Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Cerebrospinal Fluid Management Market, by Product Type
      • 7.4.4.2 RoW Cerebrospinal Fluid Management Market, by Age Group
      • 7.4.4.2 RoW Cerebrospinal Fluid Management Market, by End User
      • 7.4.4.4 RoW Cerebrospinal Fluid Management Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Cerebrospinal Fluid Management Market Global Company Share Analysis - Key 3-5 Companies

9. Cerebrospinal Fluid Management Market Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 B. Braun Melsungen AG
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Neuromedex GmbH
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Natus Medical Incorporated
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Sophysa
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Integra LifeSciences Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Spiegelberg GmbH & Co. KG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Desu Medical
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Polyganics
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 CHRISTOPH MIETHKE GMBH & CO. KG
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 HpBio Proteses Inc
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Wellong Instruments Co., Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Moller Medical GmbH
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 RAUMEDIC AG
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Anuncia Inc
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Vivonics Inc
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 CereVasc Inc
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us